PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED OR REFRACTORY SYSTEMIC ANAPLASTIC LARGE T‐CELL LYMPHOMA (ALCL) RECEIVING BRENTUXIMAB VEDOTIN AND OUTCOME AFTER TREATMENT FAILURE. (June 2017)

Record Type:: Journal Article
Title:: PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED OR REFRACTORY SYSTEMIC ANAPLASTIC LARGE T‐CELL LYMPHOMA (ALCL) RECEIVING BRENTUXIMAB VEDOTIN AND OUTCOME AFTER TREATMENT FAILURE. (June 2017)
Main Title:: PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED OR REFRACTORY SYSTEMIC ANAPLASTIC LARGE T‐CELL LYMPHOMA (ALCL) RECEIVING BRENTUXIMAB VEDOTIN AND OUTCOME AFTER TREATMENT FAILURE.
Authors:: Oki, Y.
Feldman, T.
Chihara, D.
Sanchez, L.
Fanale, M.
Connors, J.M.
Wong, S.
Savage, K.J.
Abstract:
Is Part Of:: Hematological oncology. Volume 35(2017)Supplement 2
Journal:: Hematological oncology
Issue:: Volume 35(2017)Supplement 2
Issue Display:: Volume 35, Issue 2 (2017)
Year:: 2017
Volume:: 35
Issue:: 2
Issue Sort Value:: 2017-0035-0002-0000
Page Start:: 249
Page End:: 250
Publication Date:: 2017-06
Subjects:: Hematological oncology -- Periodicals
Hematology
Medical Oncology
616.99418005
Journal URLs:: http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/hon.2438_112 ↗
Languages:: English
ISSNs:: 0278-0232
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4291.550000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 1269.xml